Diabetes Mellitus, Insulin-Dependent
Item
diagnosis of type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Diabetes disease length
Item
duration of diabetes > 1 year
boolean
C0011847 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Insulin regime Daily | Insulin pump | Insulin injection Quantity Daily
Item
daily insulin therapy (pump or at least 2 injections/day)
boolean
C0557978 (UMLS CUI [1,1])
C0332173 (UMLS CUI [1,2])
C1140609 (UMLS CUI [2])
C0199782 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0332173 (UMLS CUI [3,3])
Insulin regime Stable status | Administration of insulin Modality Change | injection of insulin | Insulin pump
Item
stable insulin regimen; not expected to change administration modality within the next 3 months (e.g., injection user switching to pump)
boolean
C0557978 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0199782 (UMLS CUI [2,1])
C0695347 (UMLS CUI [2,2])
C0392747 (UMLS CUI [2,3])
C0586328 (UMLS CUI [3])
C1140609 (UMLS CUI [4])
Skin Abnormalities Affecting Protocol Compliance | Disease Significant Affecting Protocol Compliance
Item
the presence of skin abnormalities or a significant medical disorder that in the judgment of the investigator will affect the wearing of the sensors or the completion of any aspect of the protocol.
boolean
C0037268 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0750502 (UMLS CUI [2,2])
C0392760 (UMLS CUI [2,3])
C0525058 (UMLS CUI [2,4])
Blood glucose measurement Investigational Medical Device Use of
Item
prior use of a gwb prescribed for home use (prior use of a gwb as part of a research study is allowable)
boolean
C0392201 (UMLS CUI [1,1])
C2346570 (UMLS CUI [1,2])
C1524063 (UMLS CUI [1,3])
Disease Presence
Item
the presence of any of the following diseases:
boolean
C0012634 (UMLS CUI [1,1])
C0150312 (UMLS CUI [1,2])
Asthma | systemic steroids | inhaled steroids
Item
asthma if treated with systemic or inhaled corticosteroids in the last 6 months
boolean
C0004096 (UMLS CUI [1])
C2825233 (UMLS CUI [2])
C2065041 (UMLS CUI [3])
Cystic Fibrosis
Item
cystic fibrosis
boolean
C0010674 (UMLS CUI [1])
Illness Major Interferes with Protocol Compliance
Item
other major illness that in the judgment of the investigator might interfere with the completion of the protocol
boolean
C0221423 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0525058 (UMLS CUI [1,4])
Therapeutic procedure Adequate Thyroid Diseases | Therapeutic procedure Adequate Celiac Disease
Item
adequately treated thyroid disease and celiac disease do not exclude
boolean
C0087111 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
C0040128 (UMLS CUI [1,3])
C0087111 (UMLS CUI [2,1])
C0205411 (UMLS CUI [2,2])
C0007570 (UMLS CUI [2,3])
inpatient psychiatric therapy | inpatient psychiatric therapy Caregiver Primary | inpatient psychiatric therapy parent | inpatient psychiatric therapy Guardian
Item
inpatient psychiatric treatment in the past 6 months for either the subject or the subject’s primary care giver (i.e., parent or guardian).
boolean
C2142969 (UMLS CUI [1])
C2142969 (UMLS CUI [2,1])
C0085537 (UMLS CUI [2,2])
C0205225 (UMLS CUI [2,3])
C2142969 (UMLS CUI [3,1])
C0030551 (UMLS CUI [3,2])
C2142969 (UMLS CUI [4,1])
C1274041 (UMLS CUI [4,2])
Pharmaceutical Preparations Medical contraindication Study Subject Participation Status | Glucocorticoids Oral | Glucocorticoids Inhalation
Item
current use of oral/inhaled glucocorticoids or other medications, which in the judgment of the investigator would be a contraindication to participation in the study.
boolean
C0013227 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0017710 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0017710 (UMLS CUI [3,1])
C0205535 (UMLS CUI [3,2])